Showing results (91-100 of 421) with videos related to
Sort By:
Pageof 43
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 10, 2017
Complement Alternative Pathway Deficiency in Recipients Protects Kidney Allograft From Ischemia/Reperfusion Injury and Alloreactive T Cell ResponseF Casiraghi, N Azzollini, M Todeschini, et al.Journal of Cardiovascular Pharmacology|September 8, 2000
Endothelin antagonists and renal protectionA Benigni, N Perico, G RemuzziDrugs|June 12, 2001
Renoprotective therapy in patients with nondiabetic nephropathiesR Pisoni, P Ruggenenti, G RemuzziGiornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|February 26, 2005
[Functional loss of the transplanted kidney: immunological and non-immunological factors]D Cattaneo, N Perico, G RemuzziExpert Opinion on Investigational Drugs|May 1, 1997
Recent developments in the management of membranous nephropathyA Schieppati, A Perna, G RemuzziRenal Physiology and Biochemistry|January 1, 1993
Interleukin-1 and glomerular mesangial cellsC Zoja, A Rambaldi, G RemuzziJournal of the American Society of Nephrology : JASN|July 1, 1990
Endothelin mediates the renal vasoconstriction induced by cyclosporine in the ratN Perico, J Dadan, G RemuzziJournal of Nephrology|July 1, 1997
Endothelin: a mediator of renal disease progressionI Bruzzi, G Remuzzi, A BenigniKidney International|January 1, 1997
Understanding the nature of renal disease progressionG Remuzzi, P Ruggenenti, A BenigniToxicology Letters|March 1, 1989
Abnormalities in arachidonic acid metabolites in nephrotoxic glomerular injuryC Zoja, N Perico, G RemuzziPageof 43